CFLAR and pancreatic neoplasm: Gemcitabine was also recently shown to inhibit expression of c-FLIP variant in pancreatic cancer cells [71], but whether it inhibits the transcription, enhances degradation, or prevents translation of c-FLIP remains to be found.